Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 985 products on this category.

Product data	Purity	Price range	Estimated delivery
Olaparib Impurity 27 REF: 4Z-O-032029	- - -	To inquire	Fri 27 Dec 24
Fulvestrant Impurity 16 REF: 4Z-F-3124	- - -	To inquire	Fri 27 Dec 24
(E/Z)-4,4'-Dihydroxy-N-Desmethyl Tamoxifen-d3 REF: 4Z-T-0135CAS: 1246832-93-8	- - -	To inquire	Fri 27 Dec 24
Nintedanib Impurity 99 REF: 4Z-N-066113	- - -	To inquire	Fri 27 Dec 24
Lenvatinib Impurity 26 REF: 4Z-L-124031	- - -	To inquire	Fri 27 Dec 24
Bestatin Impurity 7 REF: 4Z-B-119010	- - -	To inquire	Fri 27 Dec 24
Carfilzomib Impurity 27 REF: 4Z-C-121030	- - -	To inquire	Fri 27 Dec 24
Goserelin Impurity 6 REF: 4Z-PG-1521	- - -	To inquire	Fri 27 Dec 24
Lenvatinib Impurity 18 REF: 4Z-L-124023CAS: 2110414-05-4	- - -	To inquire	Fri 27 Dec 24
Palbociclib Lactose adduct 2 REF: 4Z-P-196041	- - -	To inquire	Fri 27 Dec 24
Olaparib Impurity 41 REF: 4Z-O-032046CAS: 2517830-61-2	- - -	To inquire	Fri 27 Dec 24
1-Hydroxybenzotriazole (HOBT) REF: 4Z-O-032035CAS: 2592-95-2 80029-43-2	- - -	To inquire	Fri 27 Dec 24
Enzalutamide Impurity 42 REF: 4Z-E-068055	- - -	To inquire	Fri 27 Dec 24
Enzalutamide Impurity 8 REF: 4Z-E-068021CAS: 1802242-47-2	- - -	To inquire	Fri 27 Dec 24
Goserelin Impurity 8 REF: 4Z-PG-1523	- - -	To inquire	Fri 27 Dec 24
Olaparib Impurity 8 REF: 4Z-O-032010CAS: 1759-53-1	- - -	To inquire	Fri 27 Dec 24
Abiraterone Impurity 18 REF: 4Z-A-8257CAS: 2307194-36-9	- - -	To inquire	Fri 27 Dec 24
Lenvatinib Impurity 27 REF: 4Z-L-124032	- - -	To inquire	Fri 27 Dec 24
Bestatin Impurity 18 HCl REF: 4Z-B-119021	- - -	To inquire	Fri 27 Dec 24
Folinic Acid Impurity 4 REF: 4Z-F-068013	- - -	To inquire	Fri 27 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Olaparib Impurity 27

Ref: 4Z-O-032029

Fulvestrant Impurity 16

Ref: 4Z-F-3124

(E/Z)-4,4'-Dihydroxy-N-Desmethyl Tamoxifen-d3

Ref: 4Z-T-0135

Nintedanib Impurity 99

Ref: 4Z-N-066113

Lenvatinib Impurity 26

Ref: 4Z-L-124031

Bestatin Impurity 7

Ref: 4Z-B-119010

Carfilzomib Impurity 27

Ref: 4Z-C-121030

Goserelin Impurity 6

Ref: 4Z-PG-1521

Lenvatinib Impurity 18

Ref: 4Z-L-124023

Palbociclib Lactose adduct 2

Ref: 4Z-P-196041

Olaparib Impurity 41

Ref: 4Z-O-032046

1-Hydroxybenzotriazole (HOBT)

Ref: 4Z-O-032035

Enzalutamide Impurity 42

Ref: 4Z-E-068055

Enzalutamide Impurity 8

Ref: 4Z-E-068021

Goserelin Impurity 8

Ref: 4Z-PG-1523

Olaparib Impurity 8

Ref: 4Z-O-032010

Abiraterone Impurity 18

Ref: 4Z-A-8257

Lenvatinib Impurity 27

Ref: 4Z-L-124032

Bestatin Impurity 18 HCl

Ref: 4Z-B-119021

Folinic Acid Impurity 4

Ref: 4Z-F-068013